Advertisement

Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use

  • V.B. Kraus
    Correspondence
    Address correspondence and reprint requests to: V.B. Kraus, Duke Molecular Physiology Institute and Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
    Affiliations
    Duke Molecular Physiology Institute and Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Search for articles by this author
  • F.J. Blanco
    Affiliations
    Grupo de Proteomica, ProteoRed/ISCIII, Servicio de Reumatologia, Instituto de Investigación Biomedica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), As Xubias, 15006, A Coruña, Spain
    Search for articles by this author
  • M. Englund
    Affiliations
    Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden

    Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston University, MA, USA
    Search for articles by this author
  • M.A. Karsdal
    Affiliations
    Nordic Bioscience, Herlev, Denmark
    Search for articles by this author
  • L.S. Lohmander
    Affiliations
    Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden

    Research Unit for Musculoskeletal Function and Physiotherapy, and Department of Orthopedics and Traumatology, University of Southern Denmark, Odense, Denmark
    Search for articles by this author
Published:April 09, 2015DOI:https://doi.org/10.1016/j.joca.2015.03.036

      Summary

      Osteoarthritis (OA) is a heterogeneous disorder. The goals of this review are (1) To stimulate use of standardized nomenclature for OA that could serve as building blocks for describing OA and defining OA phenotypes, in short to provide unifying disease concepts for a heterogeneous disorder; and (2) To stimulate establishment of ROAD (Risk of OA Development) and ROAP (Risk of OA Progression) tools analogous to the FRAX™ instrument for predicting risk of fracture in osteoporosis; and (3) To stimulate formulation of tools for identifying disease in its early preradiographic and/or molecular stages – REDI (Reliable Early Disease Identification). Consensus around more sensitive and specific diagnostic criteria for OA could spur development of disease modifying therapies for this entity that has proved so recalcitrant to date. We fully acknowledge that as we move forward, we expect to develop more sophisticated definitions, terminology and tools.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Osteoarthritis and Cartilage
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Simoncell T.
        • Barclay L.
        • Bouri K.
        • Burns K.
        • Cook K.
        • Filice R.
        • et al.
        Paving the Way for Personalized Medicine: FDA's Role in a New Era of Medical Product Development.
        (In, vol. October. Silver Spring, MD)2013: 1-61
        • Desmond-Hellmann S.
        • Sawyers C.
        • Cox D.
        • Fraser-Liggett C.
        • Galli S.
        • Goldstein D.
        • et al.
        Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease.
        National Academy of Sciences, Washington DC2011
        • Nordqvist C.
        What is Physiology.
        in: Medical News Today. Medical News Today, 2014
        • Castaneda S.
        • Roman-Blas J.A.
        • Largo R.
        • Herrero-Beaumont G.
        Osteoarthritis: a progressive disease with changing phenotypes.
        Rheumatology (Oxford). 2014; 53: 1-3
        • Helman C.G.
        Disease versus illness in general practice.
        J R Coll Gen Pract. 1981; 31: 548-552
        • Rudwaleit M.
        • van der Heijde D.
        • Landewe R.
        • Listing J.
        • Akkoc N.
        • Brandt J.
        • et al.
        The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
        Ann Rheum Dis. 2009; 68: 777-783
        • Anonymous
        Treatment Trials for Nonradiologic axSpA (nr-axSpA) Followed the Development of Diagnostic Criteria by ASAS in 2009.
        in: Rheumatology News. 2014
        • Cibere J.
        • Zhang H.
        • Garnero P.
        • Poole A.R.
        • Lobanok T.
        • Saxne T.
        • et al.
        Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study.
        Arthritis Rheum. 2009; 60: 1372-1380
        • De Vecchis R.
        • Esposito C.
        • Di Biase G.
        • Ariano C.
        • Giasi A.
        • Cioppa C.
        B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis.
        J Cardiovasc Med (Hagerstown). 2014; 15: 122-134
        • Savarese G.
        • Trimarco B.
        • Dellegrottaglie S.
        • Prastaro M.
        • Gambardella F.
        • Rengo G.
        • et al.
        Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials.
        PLoS One. 2013; 8: e58287
        • Vasara A.I.
        • Jurvelin J.S.
        • Peterson L.
        • Kiviranta I.
        Arthroscopic cartilage indentation and cartilage lesions of anterior cruciate ligament-deficient knees.
        Am J Sports Med. 2005; 33: 408-414
        • Kraus V.B.
        • Burnett B.
        • Coindreau J.
        • Cottrell S.
        • Eyre D.
        • Gendreau M.
        • et al.
        Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.
        Osteoarthritis Cartilage. 2011; 19: 515-542
        • Ling S.M.
        • Patel D.D.
        • Garnero P.
        • Zhan M.
        • Vaduganathan M.
        • Muller D.
        • et al.
        Serum protein signatures detect early radiographic osteoarthritis.
        Osteoarthritis Cartilage. 2009; 17: 43-48
        • Golightly Y.
        • Marshall1 S.
        • Kraus V.
        • Renner J.
        • Villaveces A.
        • Casteel1 C.
        • et al.
        Serum cartilage oligomeric matrix protein, hyalutonan, high-sensitivity C-reactive protein and keratan sulfate as predictors of incident radiographic knee osteoarthritis: differences by chronic knee symptoms.
        Osteoarthritis Cartilage. 2010; 18: S62-S63
        • Ruiz-Romero C.
        • Blanco F.J.
        Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis.
        Osteoarthritis Cartilage. 2010; 18: 500-509
        • Chen C.
        • Tambe D.T.
        • Deng L.
        • Yang L.
        Biomechanical properties and mechanobiology of the articular chondrocyte.
        Am J Physiol Cell Physiol. 2013; 305: C1202-C1208
        • Catterall J.B.
        • Hsueh M.F.
        • Stabler T.V.
        • McCudden C.R.
        • Bolognesi M.
        • Zura R.
        • et al.
        Protein modification by deamidation indicates variations in joint extracellular matrix turnover.
        J Biol Chem. 2012; 287: 4640-4651
        • Catterall J.
        • Zura R.
        • Bolognesi M.
        • Kraus V.
        Amino acid racemization reveals a high state of repair in knee compared with hip.
        Osteoarthritis Cartilage. 2013; 21: S108
        • Stabler T.V.
        • Byers S.S.
        • Zura R.D.
        • Kraus V.B.
        Amino acid racemization reveals differential protein turnover in osteoarthritic articular and meniscal cartilages.
        Arthritis Res Ther. 2009; 11: R34
        • Blanco F.J.
        • Ruiz-Romero C.
        New targets for disease modifying osteoarthritis drugs: chondrogenesis and Runx1.
        Ann Rheum Dis. 2013; 72: 631-634
        • Koelling S.
        • Kruegel J.
        • Irmer M.
        • Path J.R.
        • Sadowski B.
        • Miro X.
        • et al.
        Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis.
        Cell Stem Cell. 2009; 4: 324-335
        • O'Conor C.J.
        • Leddy H.A.
        • Benefield H.C.
        • Liedtke W.B.
        • Guilak F.
        TRPV4-mediated mechanotransduction regulates the metabolic response of chondrocytes to dynamic loading.
        Proc Natl Acad Sci U S A. 2014; 111: 1316-1321
        • Vincent T.L.
        Targeting mechanotransduction pathways in osteoarthritis: a focus on the pericellular matrix.
        Curr Opin Pharmacol. 2013; 13: 449-454
        • Milner P.
        • Wilkins R.
        • Gibson J.
        Cellular physiology of articular cartilage in health and disease.
        in: Rothschild B. Principles of Osteoarthritis – its Definition, Character, Derivation and Modality-related Recognition. InTech, 2012
        • Hsueh M.F.
        • Onnerfjord P.
        • Kraus V.B.
        Biomarkers and proteomic analysis of osteoarthritis.
        Matrix Biol. 2014; 39C: 56-66
        • Mateos J.
        • Lourido L.
        • Fernandez-Puente P.
        • Calamia V.
        • Fernandez-Lopez C.
        • Oreiro N.
        • et al.
        Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF.
        J Proteomics. 2012; 75: 2869-2878
        • Ritter S.Y.
        • Subbaiah R.
        • Bebek G.
        • Crish J.
        • Scanzello C.R.
        • Krastins B.
        • et al.
        Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.
        Arthritis Rheum. 2013; 65: 981-992
        • Fernandez-Puente P.
        • Mateos J.
        • Fernandez-Costa C.
        • Oreiro N.
        • Fernandez-Lopez C.
        • Ruiz-Romero C.
        • et al.
        Identification of a panel of novel serum osteoarthritis biomarkers.
        J Proteome Res. 2011; 10: 5095-5101
        • Rigoglou S.
        • Papavassiliou A.G.
        The NF-kappaB signalling pathway in osteoarthritis.
        Int J Biochem Cell Biol. 2013; 45: 2580-2584
        • Kraus V.B.
        Osteoarthritis: the zinc link.
        Nature. 2014; 507: 441-442
        • Scanzello C.R.
        • Plaas A.
        • Crow M.K.
        Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?.
        Curr Opin Rheumatol. 2008; 20: 565-572
        • Takayama K.
        • Kawakami Y.
        • Lee S.
        • Greco N.
        • Lavasani M.
        • Mifune Y.
        • et al.
        Involvement of ERCC1 in the pathogenesis of osteoarthritis through the modulation of apoptosis and cellular senescence.
        J Orthop Res. 2014; 32: 1326-1332
        • Mobasheri A.
        • Matta C.
        • Zakany R.
        • Musumeci G.
        Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis.
        Maturitas. 2015; 80: 237-244
        • Heard B.J.
        • Martin L.
        • Rattner J.B.
        • Frank C.B.
        • Hart D.A.
        • Krawetz R.
        Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
        BMC Musculoskelet Disord. 2012; 13: 126
        • Onnerfjord P.
        • Khabut A.
        • Reinholt F.P.
        • Svensson O.
        • Heinegard D.
        Quantitative proteomic analysis of eight cartilaginous tissues reveals characteristic differences as well as similarities between subgroups.
        J Biol Chem. 2012; 287: 18913-18924
        • Pritzker K.P.
        • Gay S.
        • Jimenez S.A.
        • Ostergaard K.
        • Pelletier J.P.
        • Revell P.A.
        • et al.
        Osteoarthritis cartilage histopathology: grading and staging.
        Osteoarthritis Cartilage. 2006; 14: 13-29
        • Roemer F.W.
        • Guermazi A.
        • Felson D.T.
        • Niu J.
        • Nevitt M.C.
        • Crema M.D.
        • et al.
        Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study.
        Ann Rheum Dis. 2011; 70: 1804-1809
        • Guermazi A.
        • Niu J.
        • Hayashi D.
        • Roemer F.W.
        • Englund M.
        • Neogi T.
        • et al.
        Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study).
        BMJ. 2012; 345: e5339
        • Choi J.A.
        • Gold G.E.
        MR imaging of articular cartilage physiology.
        Magn Reson Imaging Clin N Am. 2011; 19: 249-282
        • Hunter D.
        • Lohmander L.
        • Makovey J.
        • Tamez-Pena J.
        • Totterman S.
        • Schreyer E.
        • et al.
        The effect of anterior cruciate ligament injury on bone curvature: the KANON Trial.
        Osteoarthritis Cartilage. 2014; 22: 959-968
        • Reichenbach S.
        • Guermazi A.
        • Niu J.
        • Neogi T.
        • Hunter D.J.
        • Roemer F.W.
        • et al.
        Prevalence of bone attrition on knee radiographs and MRI in a community-based cohort.
        Osteoarthritis Cartilage. 2008; 16: 1005-1010
        • Hunter D.J.
        • Arden N.
        • Conaghan P.G.
        • Eckstein F.
        • Gold G.
        • Grainger A.
        • et al.
        Definition of osteoarthritis on MRI: results of a Delphi exercise.
        Osteoarthritis Cartilage. 2011; 19: 963-969
        • Moller I.
        • Bong D.
        • Naredo E.
        • Filippucci E.
        • Carrasco I.
        • Moragues C.
        • et al.
        Ultrasound in the study and monitoring of osteoarthritis.
        Osteoarthritis Cartilage. 2008; 16: S4-S7
        • Keen H.I.
        • Wakefield R.J.
        • Grainger A.J.
        • Hensor E.M.
        • Emery P.
        • Conaghan P.G.
        Can ultrasonography improve on radiographic assessment in osteoarthritis of the hands? A comparison between radiographic and ultrasonographic detected pathology.
        Ann Rheum Dis. 2008; 67: 1116-1120
        • Ashraf S.
        • Walsh D.A.
        Angiogenesis in osteoarthritis.
        Curr Opin Rheumatol. 2008; 20: 573-580
        • Kloppenburg M.
        • Kwok W.Y.
        Hand osteoarthritis – a heterogeneous disorder.
        Nat Rev Rheumatol. 2012; 8: 22-31
        • Haugen I.K.
        • Lillegraven S.
        • Slatkowsky-Christensen B.
        • Haavardsholm E.A.
        • Sesseng S.
        • Kvien T.K.
        • et al.
        Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score.
        Ann Rheum Dis. 2011; 70: 1033-1038
        • McDonough C.M.
        • Jette A.M.
        The contribution of osteoarthritis to functional limitations and disability.
        Clin Geriatr Med. 2010; 26: 387-399
        • Block J.A.
        • Shakoor N.
        The biomechanics of osteoarthritis: implications for therapy.
        Curr Rheumatol Rep. 2009; 11: 15-22
        • Roos E.M.
        • Juhl C.B.
        Osteoarthritis 2012 year in review: rehabilitation and outcomes.
        Osteoarthritis Cartilage. 2012; 20: 1477-1483
        • Kiviranta P.
        • Lammentausta E.
        • Toyras J.
        • Kiviranta I.
        • Jurvelin J.S.
        Indentation diagnostics of cartilage degeneration.
        Osteoarthritis Cartilage. 2008; 16: 796-804
        • Shapiro L.M.
        • Gold G.E.
        MRI of weight bearing and movement.
        Osteoarthritis Cartilage. 2012; 20: 69-78
        • Sutter E.G.
        • Widmyer M.R.
        • Utturkar G.M.
        • Spritzer C.E.
        • Garrett Jr., W.E.
        • DeFrate L.E.
        In vivo measurement of localized tibiofemoral cartilage strains in response to dynamic activity.
        Am J Sports Med. 2015; 43: 370-376
        • Ornetti P.
        • Maillefert J.F.
        • Laroche D.
        • Morisset C.
        • Dougados M.
        • Gossec L.
        Gait analysis as a quantifiable outcome measure in hip or knee osteoarthritis: a systematic review.
        Jt Bone Spine. 2010; 77: 421-425
        • Kraus V.
        Preclinical osteoarthritis.
        in: Hochberg M. Silman A. Smolen J. Weinblatt M. Weisman M. Rheumatology. Mosby Elsevier, Philadelphia2014: 1498-1547
        • Zhang W.
        • Doherty M.
        • Peat G.
        • Bierma-Zeinstra M.A.
        • Arden N.K.
        • Bresnihan B.
        • et al.
        EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.
        Ann Rheum Dis. 2010; 69: 483-489
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • Benjamin E.J.
        • Berry J.D.
        • Blaha M.J.
        • et al.
        Heart disease and stroke statistics – 2014 update: a report from the American Heart Association.
        Circulation. 2014; 129: e28-e292
        • Vaidya V.S.
        • Ozer J.S.
        • Dieterle F.
        • Collings F.B.
        • Ramirez V.
        • Troth S.
        • et al.
        Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.
        Nat Biotechnol. 2010; 28: 478-485
        • Bonventre J.V.
        • Vaidya V.S.
        • Schmouder R.
        • Feig P.
        • Dieterle F.
        Next-generation biomarkers for detecting kidney toxicity.
        Nat Biotechnol. 2010; 28: 436-440
        • Henriksen K.
        • Bohren K.M.
        • Bay-Jensen A.C.
        • Karsdal M.A.
        Should biochemical markers of bone turnover be considered standard practice for safety pharmacology?.
        Biomarkers. 2010; 15: 195-204
        • Levey A.S.
        • Inker L.A.
        • Coresh J.
        GFR estimation: from physiology to public health.
        Am J Kidney Dis. 2014; 63: 820-834
        • Genovese F.
        • Manresa A.A.
        • Leeming D.J.
        • Karsdal M.A.
        • Boor P.
        The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?.
        Fibrogenesis Tissue Repair. 2014; 7: 4
        • Karsdal M.A.
        • Krarup H.
        • Sand J.M.
        • Christensen P.B.
        • Gerstoft J.
        • Leeming D.J.
        • et al.
        Review article: the efficacy of biomarkers in chronic fibroproliferative diseases – early diagnosis and prognosis, with liver fibrosis as an exemplar.
        Aliment Pharmacol Ther. 2014; 40: 233-249
        • Michalopoulos G.K.
        Advances in liver regeneration.
        Expert Rev Gastroenterol Hepatol. 2014; : 1-11
        • Shoup M.
        • Gonen M.
        • D'Angelica M.
        • Jarnagin W.R.
        • DeMatteo R.P.
        • Schwartz L.H.
        • et al.
        Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.
        J Gastrointest Surg. 2003; 7: 325-330
        • Schindl M.J.
        • Redhead D.N.
        • Fearon K.C.
        • Garden O.J.
        • Wigmore S.J.
        The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection.
        Gut. 2005; 54: 289-296
        • Vauthey J.N.
        • Chaoui A.
        • Do K.A.
        • Bilimoria M.M.
        • Fenstermacher M.J.
        • Charnsangavej C.
        • et al.
        Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.
        Surgery. 2000; 127: 512-519
        • Lawrence J.S.
        • Bremner J.M.
        • Bier F.
        Osteo-arthrosis. Prevalence in the population and relationship between symptoms and x-ray changes.
        Ann Rheum Dis. 1966; 25: 1-24
        • Dieppe P.A.
        • Lohmander L.S.
        Pathogenesis and management of pain in osteoarthritis.
        Lancet. 2005; 365: 965-973
        • Arendt-Nielsen L.
        • Nie H.
        • Laursen M.B.
        • Laursen B.S.
        • Madeleine P.
        • Simonsen O.H.
        • et al.
        Sensitization in patients with painful knee osteoarthritis.
        Pain. 2010; 149: 573-581
        • Wluka A.E.
        • Wolfe R.
        • Stuckey S.
        • Cicuttini F.M.
        How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis?.
        Ann Rheum Dis. 2004; 63: 264-268
        • Kim D.H.
        • Schwartz C.E.
        The genetics of pain: implications for evaluation and treatment of spinal disease.
        Spine J. 2010; 10: 827-840
        • Altman R.
        • Asch E.
        • Bloch D.
        • Bole G.
        • Borenstein D.
        • Brandt K.
        • et al.
        Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.
        Arthritis Rheum. 1986; 29: 1039-1049
        • Kanis J.A.
        • Oden A.
        • McCloskey E.V.
        • Johansson H.
        • Wahl D.A.
        • Cooper C.
        A systematic review of hip fracture incidence and probability of fracture worldwide.
        Osteoporos Int. 2012; 23: 2239-2256
        • Fardellone P.
        Predicting the fracture risk in 2008.
        Jt Bone Spine. 2008; 75: 661-664
        • Kerkhof H.J.
        • Bierma-Zeinstra S.M.
        • Arden N.K.
        • Metrustry S.
        • Castano-Betancourt M.
        • Hart D.J.
        • et al.
        Prediction model for knee osteoarthritis incidence, including clinical, genetic and biochemical risk factors.
        Ann Rheum Dis. 2014; 73: 2116-2121
        • Smolen J.S.
        • Aletaha D.
        Forget personalised medicine and focus on abating disease activity.
        Ann Rheum Dis. 2013; 72: 3-6
        • Misko T.P.
        • Radabaugh M.R.
        • Highkin M.
        • Abrams M.
        • Friese O.
        • Gallavan R.
        • et al.
        Characterization of nitrotyrosine as a biomarker for arthritis and joint injury.
        Osteoarthritis Cartilage. 2013; 21: 151-156
        • Katz D.
        • Ather A.
        Preventive medicine, integrative medicine & the health of the public.
        in: Commissioned for the IOM Summit on Integrative Medicine and the Health of the Public. Institute of Medicine, 2009: 1-45
        • El-Zayadi A.R.
        Hepatic steatosis: a benign disease or a silent killer.
        World J Gastroenterol. 2008; 14: 4120-4126